[18F]Fluorocholine PET/MRI and [18F]Fluorocholine PET/CT as first- and second-line imaging in primary hyperparathyroidism – who takes the lead?
European Journal of Nuclear Medicine and Molecular Imaging · 2025-11 · 52 (13) · 5165-5174
DOI: 10.1007/s00259-025-07373-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 30.05.2025. Verfasst von Petra Petranović Ovčariček und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia. p.petranovic@gmail.com. Hauptthemen laut MEDLINE: Choline, Positron Emission Tomography Computed Tomography, Magnetic Resonance Imaging, Hyperparathyroidism, Primary. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Zurich.
Abstract (Originalsprache)
Purpose
Accurate preoperative localization of hyperfunctioning parathyroid glands is essential for enabling a focused surgical approach in patients with primary hyperparathyroidism (pHPT). Our study aims to determine the diagnostic value of 18 F-fluorocholine positron emission tomography/magnetic resonance imaging ([ 18 F]FCH PET/MRI) and [ 18 F]FCH PET/computed tomography (PET/CT) in identifying parathyroid adenomas.
Methods
We conducted a retrospective study to assess the diagnostic accuracy of [ 18 F]FCH PET/MRI and [ 18 F]FCH PET/CT as first- and second-line methods for detecting parathyroid adenomas in patients with pHPT. The primary endpoints included patient-based sensitivity, specificity, and positive predictive value (PPV), with intraoperative surgical localization and histopathological analysis serving as reference, i.e., gold standard.
Results
The study included 322 patients. A total of 264 patients underwent [ 18 F]FCH PET/MRI, thereof 155 and 109 as a second- and first-line method, respectively. [ 18 F]FCH PET/CT was performed in 58 patients, thereof 44 and 14 in a second- and first-line setting, respectively. Total sensitivity, specificity, PPV, negative predictive value (NPV), and diagnostic accuracy of [ 18 F]FCH PET/MRI were 0.967, 0.818, 0.983, 0.692, and 0.955, respectively, while the same parameters for [ 18 F]FCH PET/CT were 0.980, 0.875, 0.980, 0.875, and 0.966, respectively (all p > 0.05). There was also no difference between the two methods in the first- or second-line imaging scenarios.
Conclusion
Both [ 18 F]FCH PET/MRI and [ 18 F]FCH PET/CT are highly accurate imaging modalities for localizing parathyroid adenomas in both first- and second-line settings. They can be regarded as “top-scoring” or “one-stop-shop” techniques for preoperative assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia. p.petranovic@gmail.com.
- School of Medicine, University of Zagreb, Zagreb, Croatia. p.petranovic@gmail.com.
- Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland. p.petranovic@gmail.com.
- Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Faculty of Medicine, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Petra Petranović Ovčariček
Förderung
- University of Zurich
Zitieren
APA
Petranović Ovčariček, P., Schaab, J., Beintner-Skawran, S., Maurer, A., Rupp, N. J., Ikenberg, K., Morand, G. B., Mueller, S. A., Vetter, D., Liberini, V., Giovanella, L., & Huellner, M. W. (2025). [18F]Fluorocholine PET/MRI and [18F]Fluorocholine PET/CT as first- and second-line imaging in primary hyperparathyroidism – who takes the lead?. European Journal of Nuclear Medicine and Molecular Imaging, 52(13), 5165-5174. https://doi.org/10.1007/s00259-025-07373-1
Vancouver
Petranović Ovčariček P, Schaab J, Beintner-Skawran S, Maurer A, Rupp NJ, Ikenberg K, et al. [18F]Fluorocholine PET/MRI and [18F]Fluorocholine PET/CT as first- and second-line imaging in primary hyperparathyroidism – who takes the lead?. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(13):5165-5174. doi:10.1007/s00259-025-07373-1
BibTeX
@article{PetranoviOvariek2025,
author = {Petranović Ovčariček, Petra and Schaab, Jan and Beintner-Skawran, Stephan and Maurer, Alexander and Rupp, Niels J and Ikenberg, Kristian and Morand, Grégoire B and Mueller, Simon A and Vetter, Diana and Liberini, Virginia and Giovanella, Luca and Huellner, Martin W},
title = {[18F]Fluorocholine PET/MRI and [18F]Fluorocholine PET/CT as first- and second-line imaging in primary hyperparathyroidism – who takes the lead?},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
volume = {52},
number = {13},
pages = {5165--5174},
doi = {10.1007/s00259-025-07373-1}
}
EUVIMED